Clinical Trial Update: A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants [Phase 1]

View source ↗

Summary

Mage Biologics conducted a Phase 1 safety study of an oral biologic in healthy participants; the trial for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Oral Biologic (Mage Biologics)

Snippet

Sponsor: Mage Biologics | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED